Request Demo
Last update 08 May 2025
Novel erythropoiesis stimulant(Shanghai Qiangbang Biological Technology Co Ltd)
Last update 08 May 2025
Overview
Basic Info
Drug Type Colony-stimulating factors |
Synonyms- |
Target |
Action agonists, stimulants |
Mechanism EPO receptor agonists(Erythropoietin receptor agonists), Erythropoiesis stimulants(Erythropoiesis stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with Novel erythropoiesis stimulant(Shanghai Qiangbang Biological Technology Co Ltd)CTR20180129
皮下注射长效人红细胞生长刺激素注射液治疗慢性透析肾性贫血的安全性、药代动力学及初步药效的临床研究
[Translation] Clinical study on the safety, pharmacokinetics and preliminary efficacy of subcutaneous long-acting human erythrocyte growth stimulating hormone injection in the treatment of chronic dialysis renal anemia
JPRN-jRCT1090220102
The examination of comparison about the pain relief at the time of a hypodermic injection of erythropoiesis stimulating agent.
100 Clinical Results associated with Novel erythropoiesis stimulant(Shanghai Qiangbang Biological Technology Co Ltd)
Login to view more data
100 Translational Medicine associated with Novel erythropoiesis stimulant(Shanghai Qiangbang Biological Technology Co Ltd)
Login to view more data
100 Patents (Medical) associated with Novel erythropoiesis stimulant(Shanghai Qiangbang Biological Technology Co Ltd)
Login to view more data
100 Deals associated with Novel erythropoiesis stimulant(Shanghai Qiangbang Biological Technology Co Ltd)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Anemia | Phase 1 | China | - | |
| Anemia | Phase 1 | China | - | |
| Anemia | Phase 1 | China | - |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Not Applicable | 183 | (zvxohjlkcp) = kqogqxfdow gukxsppnoj (aysraoejtk ) | - | 10 Jun 2022 | |||
Not Applicable | 137 | (vvevppcmqt) = ljyhpxvejx fsdzsgefgi (ppwgidytct ) View more | - | 21 May 2015 | |||
Not Applicable | - | (Oncology Analytics (OA) cancer care quality initiative) | dtkaiqvpmf(yvkimiufco) = zzezudvmgy fgqzsjlpda (tcdeinisif ) | Positive | 20 May 2014 | ||
Not Applicable | Ovarian Cancer Second line | - | (Patients after APPRISE mandate) | wfqgkgsogm(odjclapofm) = gzgfqkufis wbvnevglla (zganhmhtqa ) | Positive | 20 May 2012 | |
(Patients before APPRISE mandate) | wfqgkgsogm(odjclapofm) = zlzctdunee wbvnevglla (zganhmhtqa ) |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free